GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimta Labs Ltd (BOM:524394) » Definitions » Gross Margin %

Vimta Labs (BOM:524394) Gross Margin % : 77.06% (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Vimta Labs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Vimta Labs's Gross Profit for the three months ended in Dec. 2024 was ₹693 Mil. Vimta Labs's Revenue for the three months ended in Dec. 2024 was ₹899 Mil. Therefore, Vimta Labs's Gross Margin % for the quarter that ended in Dec. 2024 was 77.06%.


The historical rank and industry rank for Vimta Labs's Gross Margin % or its related term are showing as below:

BOM:524394' s Gross Margin % Range Over the Past 10 Years
Min: 63.17   Med: 70.91   Max: 76.56
Current: 75


During the past 13 years, the highest Gross Margin % of Vimta Labs was 76.56%. The lowest was 63.17%. And the median was 70.91%.

BOM:524394's Gross Margin % is ranked better than
81.37% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 47.58 vs BOM:524394: 75.00

Vimta Labs had a gross margin of 77.06% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Vimta Labs was 1.50% per year.


Vimta Labs Gross Margin % Historical Data

The historical data trend for Vimta Labs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimta Labs Gross Margin % Chart

Vimta Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.88 70.70 71.30 76.56 76.03

Vimta Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.70 68.75 77.11 78.35 77.06

Competitive Comparison of Vimta Labs's Gross Margin %

For the Diagnostics & Research subindustry, Vimta Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimta Labs's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimta Labs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Vimta Labs's Gross Margin % falls into.


;
;

Vimta Labs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Vimta Labs's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=2419.8 / 3182.61
=(Revenue - Cost of Goods Sold) / Revenue
=(3182.61 - 762.85) / 3182.61
=76.03 %

Vimta Labs's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=692.9 / 899.23
=(Revenue - Cost of Goods Sold) / Revenue
=(899.23 - 206.3) / 899.23
=77.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vimta Labs  (BOM:524394) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vimta Labs had a gross margin of 77.06% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Vimta Labs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Vimta Labs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimta Labs Business Description

Traded in Other Exchanges
Address
Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.

Vimta Labs Headlines

No Headlines